Ravi S. Chari, SVP-Clinical Excellence at HCA Healthcare, Inc. (HCA), sold 5,702 shares at $102.01 ($582K) on 2018-02-02, disclosed to the SEC on 2018-02-02.
Open-market sale of $582k HCA by SVP-Clinical Excellence. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| HCA | SELL | 2017-02-03 | $1.3M | — | Filing → |